Luciano A. Marraffini
Dr. Marraffini received his undergraduate degree from the University of Rosario in Argentina in 1998 and his Ph.D. from the University of Chicago in 2007, studying bacterial pathogenesis in the laboratory of Dr. Olaf Schneewind. He was a postdoc at Northwestern University from 2008 to 2010 with Dr. Erik Sontheimer, where he pioneered studies on CRISPR-Cas immunity. Dr. Marraffini determined that that CRISPR-Cas systems target DNA molecules in a sequence-specific manner, a study that was key to understand the mechanisms of CRISPR immunity at the molecular level. This finding also predicted the existence of RNA-programmable Cas nucleases and their applications. In 2010 he joined Rockefeller University as assistant professor. He is a 2012 Rita Allen Foundation Scholar and a 2011 Searle Scholar and is the recipient of a 2012 NIH Director’s New Innovator Award, a 2015 Burroughs Wellcome Fund PATH Award, the Earl and Thressa Stadtman Scholar Award from the American Society for Biochemistry and Molecular Biology, and the Hans Sigrist Prize from the University of Bern. For more information about Dr. Marraffini please visit http://marraffini.rockefeller.edu.